MedPharm || طبصيدلة

Which one of the following is FDA approved for the treatment of moderate-to-severe dyspareunia and vaginal dryness in post menopause women:

Regarding hormone therapy in menopausal females. Which of the following are serious health risks that have been associated with menopausal hormone therapy?

About menopause clinical presentation. Which of the following statements about menopause symptom(s) do you consider correct ?

Regarding hormone therapy in women‚ the intravaginal DHEA has FDA approval for the treatment of moderate to-severe dyspareunia is;

A 60-year-old woman with severe hot flashes is interested in testosterone therapy. What is the MOST important information to discuss with her regarding potential risk and benefits?

Hot flash is common in menopause. If it accompanied with sleep disturbance‚ the drug of choice will be

Diagnosis of menopause depend on subjective and laboratory parameters. Retrospective diagnosis of menopause requires occurrence of amenorrhea for

The following condition are absolute contraindication for hormonal replacement therapy EXCEPT:

Combined hormonal contraceptives (CHCs) can be used in perimenopausal women. What is not a risk factor that prevent CHC using

Addition of a progestene for estrogen replacement therapy in postmenopausal women is recommended because the progestene

Regarding hormonal replacement therapy, The benefits of hormonal replacement therapy include

Contraindication to HRT include all the following EXCEPT

For diagnosis of menopause, The most important parameter in the diagnosis of menopause is

Menopause associated with several clinical symptoms. Vasomotor symptom (s) of menopause all true except:-

Estrogens have important roles in treatment of post menopausal symptoms. When compared to oral estrogen, transdermal estrogen is

IUD is well known to have minimal systemic adverse effects, that is attributed to the primary contraceptive mechanism of the Levonorgestrel IUD through:

The following are the disadvantages of combined oral contraceptive pills, EXCEPT

What is the type should not be left in place for more than 48 hours because of the risk of toxic shock syndrome